258 related articles for article (PubMed ID: 27684975)
1. Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls.
Asirvatham JR; Falcone MM; Kleer CG
Arch Pathol Lab Med; 2016 Oct; 140(10):1045-51. PubMed ID: 27684975
[TBL] [Abstract][Full Text] [Related]
2. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
Elayat G; Selim AG; Wells CA
Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
[TBL] [Abstract][Full Text] [Related]
3. Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.
Visscher DW
Arch Pathol Lab Med; 2009 Nov; 133(11):1817-21. PubMed ID: 19886717
[TBL] [Abstract][Full Text] [Related]
4. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
Seidman JD; Ashton M; Lefkowitz M
Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
[TBL] [Abstract][Full Text] [Related]
5. Non-operative breast pathology: apocrine lesions.
Wells CA; El-Ayat GA
J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
[TBL] [Abstract][Full Text] [Related]
6. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.
Fuehrer N; Hartmann L; Degnim A; Allers T; Vierkant R; Frost M; Visscher D
Arch Pathol Lab Med; 2012 Feb; 136(2):179-82. PubMed ID: 22288965
[TBL] [Abstract][Full Text] [Related]
7. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy.
Hou Y; Chaudhary S; Gao FF; Li Z
Ann Diagn Pathol; 2016 Oct; 24():4-6. PubMed ID: 27649945
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
9. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
10. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management.
Calhoun BC; Booth CN
Hum Pathol; 2014 Oct; 45(10):2130-5. PubMed ID: 25106711
[TBL] [Abstract][Full Text] [Related]
11. The Histologic Spectrum of Apocrine Lesions of the Breast.
Durham JR; Fechner RE
Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle aspiration cytology of apocrine adenosis of the breast: report on three cases.
Watanabe K; Nomura M; Hashimoto Y; Hanzawa M; Hoshi T
Diagn Cytopathol; 2007 May; 35(5):296-9. PubMed ID: 17427223
[TBL] [Abstract][Full Text] [Related]
13. Cytologic findings of atypical adenosis of the breast. A case report.
Kaufman D; Sanchez M; Mizrachy B; Jaffer S
Acta Cytol; 2002; 46(2):369-72. PubMed ID: 11917587
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic pitfalls in fine needle aspiration cytology of atypical apocrine metaplasia in a breast lesion. A case report.
Gupta D; Wolf JA; Rubenchik IA; Middleton LP
Acta Cytol; 2002; 46(4):749-52. PubMed ID: 12146046
[TBL] [Abstract][Full Text] [Related]
15. Apocrine lesions of the breast.
Quinn CM; D'Arcy C; Wells C
Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
[TBL] [Abstract][Full Text] [Related]
16. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions.
Chang Sen LQ; Berg WA; Carter GJ
Breast J; 2017 Sep; 23(5):569-578. PubMed ID: 28333404
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
Selim AG; Wells CA
J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
[TBL] [Abstract][Full Text] [Related]
18. Apocrine sclerosing adenosis of the sweat glands.
Collina G; Di Tommaso L; Magrini E; Reggiani M
Histopathology; 2004 Oct; 45(4):414-5. PubMed ID: 15469482
[No Abstract] [Full Text] [Related]
19. The diagnostic utility of EZH2 H-score and Ki-67 index in non-invasive breast apocrine lesions.
Vougiouklakis T; Belovarac BJ; Lytle A; Chiriboga L; Ozerdem U
Pathol Res Pract; 2020 Sep; 216(9):153041. PubMed ID: 32825929
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast.
Selim AG; Ryan A; El-Ayat GA; Wells CA
Cancer Detect Prev; 2001; 25(3):262-7. PubMed ID: 11425268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
